FindTrial
Sign In

Research to combat diabetes using genetics and novel technologies

NIHR Global Heath Research Unit on Global Diabetes Outcomes Research

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/09/009909
Enrollment
30000
Registered
2017-09-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diabetes

Interventions

None listed

Sponsors

Madras Diabetes Research Foundation
Lead Sponsor
School of Medicine University of Dundee
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Type 2 Diabetes Cohort Study Those who have at least 4 or more follow ups in the hospital Cross sectional study Individuals aged � 20 years Willing to participate in the study Usual resident of the selected locality

Exclusion criteria

Exclusion criteria: Known cases of type 1 diabetes Diabetes secondary to other causes eg.chronic pancreatitis Under 20 years of age or over 80 years of age Refused consent

Design outcomes

Secondary

MeasureTime frame
To establish genetic determinants of genetic complicationsTimepoint: 3 years—

Primary

MeasureTime frame
To provide a low cost, agile and sustainable solution supported by telemedicine for outreach to the poorest populations in rural India. To determine genomic signatures of diabetes subtypes specific to the Indian sub-continent including those defined by therapeutic response to established anti-diabetic medications.Timepoint: 4 years—

Countries

India

Contacts

Public ContactDr V Mohan

Madras Diabetes Research Foundation

drmohans@diabetes.ind.in43968888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026